Antihypertensive drug class and impaired fasting glucose: A risk association study among Chinese patients with uncomplicated hypertension

BMC Clinical Pharmacology

Volumn 8, Issue , 2008, Pages

  Wong, Martin C S ^a   Jiang, Johnny Y ^a   Fung, H ^b   Griffiths, Sian ^a   Mercer, Stewart ^a,c  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; POTASSIUM SPARING DIURETIC AGENT; THIAZIDE DIURETIC AGENT; VASODILATOR AGENT;

ADULT; AGE; AGED; ARTICLE; CHINESE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; HONG KONG; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTIPLE REGRESSION; PRIMARY HEALTH CARE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; BLOOD; CHINA; CLASSIFICATION; CLINICAL TRIAL; DRUG EFFECT; GLUCOSE BLOOD LEVEL; MIDDLE AGED; MULTICENTER STUDY; REGRESSION ANALYSIS; RISK; SOCIAL CLASS;

ANTIHYPERTENSIVE AGENTS; BLOOD GLUCOSE; CHINA; FASTING; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RISK; SOCIAL CLASS;

EID: 52949146436     PISSN: None     EISSN: 14726904     Source Type: Journal    
DOI: 10.1186/1472-6904-8-6     Document Type: Article

References (47)

1. Saydah SH Fradkin J Cowie CC Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes JAMA 2004, 291:335-342. 10.1001/jama.291.3.335 14734596
2. Mugo MN Link D Stump CS Sowers JR Insulin Resistance and Diabetes in Hypertension Comprehensive Hypertension Mosby, Inc Lip GYH, Hall JE 2007, 682.
3. Salmasi A-M Alimo A Dancy M Prevalence of unrecognized abnormal glucose tolerance in patients attending a hospital hypertension clinic Am J Hypertens 2004, 17:483-488. 10.1016/j.amjhyper.2004.01.011 15177519
4. Mooradian AD Cardiovascular disease in type 2 diabetes mellitus: Current management guidelines Arch Intern Med 2003, 163:33-40. 10.1001/ archinte.163.1.33 12523914
5. Creager MA Luscher TF Cosentino F Beckman JA Diabetes and vascular disease: Pathophysiology, clinical consequences, and medical therapy Circulation 2003, 108:1527-1532. 10.1161/01.CIR.0000091257.27563.32 14504252
6. Tedesco MA Natale F Di Savo G Caputo S Capasso M Calabro R Effects of coexisting hypertension and type II diabetes mellitus on arterial stiffness J Hum Hypertens 2004, 18:469-473. 10.1038/sj.jhh.1001690 14985776
7. Ronnback M Fagerudd J Forsblom C Pettersson-Fernholm K Reunanen A Groop PH Finnish Diabetic Nephropathy (FinnDiane) Study Group Altered age-related blood pressure pattern in type I diabetes Circulation 2004, 110:1076-1082. 10.1161/01.CIR.0000139903.29522.8D 15326070
8. American Diabetes Association Hypertension management in adults with diabetes Diabetes Care 2004, 27(suppl 1):S65-S82. 14693929
9. Chobanian AV Bakris GL Black HR Cushman WC Green LA Izzo JL Jr Jones DW Materson BJ Oparil S Wright JT Jr Roccella EJ National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National High Blood Pressure Education Program Coordinating Committee The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC-7 report JAMA 2003, 289:2560-2572. 10.1001/jama.289.19.2560 12748199
10. Samuelsson O Pennert K Andersson O Berglund G Hedner T Persson B Wedel H Wilhelmsen L Diabetes mellitus and raised serum triglyceride concentration in treated hypertension - are they of prognostic importance? BMJ 1996, 313:660-663. 2352005 8811759
11. Murtagh J General Practice McGraw-Hill Bool Company Australia Pty Limited second 1999 Table 111.6:1082.
12. Filler Diuretics should be the first line treatment for hypertension BMJ 2003, 327.
13. Wong MCS Chung RY The prescription pattern of first-line anti-hypertensives among family medicine trainees in Hong Kong Part 1: in the absence of concomitant cardiovascular risk factors HK Pract 2004, 26:420-429.
14. Wong MCS Chung RY The prescription pattern of first-line antihypertensives among family medicine trainees in Hong Kong - Part 2: in the presence of diabetes HK Pract 2005, 27:83-93.
15. Cheung NT Health informatics, Hospital Authority, Hong Kong Realizing the benefits of eHealth in Hong Kong 2007. http://www.ehealth.org.hk/ Speaker/Dr%20Ngai%20Tseung%20CHEUNG.pdf
16. Wong MCS Jiang Y Tang JL Lam A Fung H Mercer SW Health services research in the public healthcare system in Hong Kong: An analysis of over 1 million antihypertensive prescriptions between 2004-2007 as an example of the potential and pitfalls of using routinely collected electronic patient data BMC Health Services Research 2008, 8:138. 2453117 18578878 10.1186/1472-6963-8-138
17. Population by-census, 2006, Hong Kong Special Administrative Region, China http://www.bycensus2006.gov.hk/data/data2/index.htm
18. Lithell HO Hyperinsulinemia, insulin resistance, and the treatment of hypertension Am J Hypertens 1996, 9:150S-154S. 10.1016/ 0895-7061(96)00290-7 8931847
19. Goldner MG Zarowitz H Akgun S Hyperglycemia and glycosuria due to thiazide derivatives administered in diabetes mellitus N Engl J Med 1960, 262:403-405. 13850721
20. SHEP Cooperative Research Group Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension JAMA 1991, 265:3255-64. 10.1001/jama.265.24.3255 2046107
21. MRC. Medical Research Council Working Party MRC trial of treatment of mild hypertension: Principal results BMJ 1985, 291:97-104. 1416260 2861880
22. Wilhelmsen L Berglund G Elmfeldt D Fitzsimons T Holzgreve H Hosie J Hornkvist PE Pennert K Tuomilehto J Wedel H Beta blockers versus diuretics in hypertensive men: Main results from the HAPPHY Trial Journal of Hypertension 1987, 5:561-72. 10.1097/00004872-198710000-00009 2892881
23. Amery A Birkenhager W Brixko P Bulpitt C Clement D Deruyttere M De Schaepdryver A Dollery C Fagard R Forette F Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly Trial Lancet 1985, 1:1349-54. 10.1016/S0140-6736(85)91783-0 2861311
24. Williams WR Schneider KA Borhani NO Schnaper HW Slotkoff LM Ellefson RD The relationship between diuretics and serum cholesterol in Hypertension Detection and Follow-up Program participants Am J Prev Med 1986, 2:248-55. 3453187
25. Dahlof B Lindholm LH Hansson L Schersten B Ekbom T Wester PO Morbidity and mortality in the Swedish Trial of Older Patients with Hypertension (STOP-Hypertension) Lancet 1991, 338:1281-85. 10.1016/ 0140-6736(91)92589-T 1682683
26. Hebert PR Moser M Mayer J Glynn RJ Hennekens CH Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease Arch Intern Med 1993, 153:578-81. 10.1001/ archinte.153.5.578 8439221
27. Black HR Elliott WJ Grandits G for the CONVINCE Research Group Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular Endpoints (CONVINCE) Trial JAMA 2003, 289:2073-82. 10.1001/jama.289.16.2073 12709465
28. Gress TW Nieto FJ Shahar E Wofford MR Brancati FL Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus N Engl J med 2000, 342:905-912. 10.1056/NEJM200003303421301 10738048
29. Curb JD Pressel SL Cutler JA Savage PJ Applegate WB Black H Camel G Davis BR Frost PH Gonzalez N Guthrie G Oberman A Rutan GH Stamler J Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension JAMA 1996, 276:1886-92. 10.1001/jama.276.23.1886 8968014
30. Kostis JB Wilson AC Freudenberger RS Cosgrove NM Pressel SL Davis BR Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes Am J Cardiol 2005, 95:29-35. 10.1016/j.amjcard.2004.08.059 15619390
31. Messerli FH Grossman E Leonetti G Antihypertensive therapy and new onset diabetes J Hypertens 2004, 22:1845-1847. 10.1097/ 00004872-200410000-00001 15361750
32. Dunder K Lind L Zethelius B Berglund L Lithell H Increase in blood glucose concentration during antihypertensive treatment as a predictor of myocardial infarction: Population based cohort study BMJ 2003, 326:681. 152364 12663403 10.1136/bmj.326.7391.681
33. Hansson L Lindholm LH Niskanen L Lanke J Hedner T Niklason A Luomanmaki K Dahlof B de Faire U Morlin C Karlberg BE Wester PO Bjorck JE Effect of angiotensin converting enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPP) randomized trial Lancet 1999, 353:611-16. 10.1016/S0140-6736(98)05012-0 10030325
34. HOPE. Heart Outcome Prevention Evaluation (HOPE) Study Investigators Effects of an angiotensin converting enzyme inhibitor, ramipril, on cardiovascular events in high risk patients N Engl J Med 2000, 342:145-53. 10.1056/NEJM200001203420301 10639539
35. Dahlof B Devereux RB Kjeldsen SE Julius S Beevers G de Faire U Fyhrquist F Ibsen H Kristiansson K Lederballe-Pedersen O Lindholm LH Nieminen MS Omvik P Oparil S Wedel H For the LIFE Study Group. Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): A randomized trial against atenolol Lancet 2002, 359:995-1003. 10.1016/S0140-6736(02)08089-3 11937178
36. Carter BL Baslie J Development of diabetes with thiazide diuretics: The potassium issue J Clin Hypertension 2005, 7:638-40. 10.1111/ j.1524-6175.2005.04144.x
37. Julius S Kjeldsen SE Weber M Brunner HR Ekman S Hansson L Hua T Laragh J McInnes GT Mitchell L Plat F Schork A Smith B Zanchetti A VALUE trial group Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: The VALUE randomized trial Lancet 2004, 363:2022-31. 10.1016/S0140-6736(04)16451-9 15207952
38. Fridlyand Leonid E Philipson Louis H Reactive species, cellular repair and risk factors in the onset of type 2 diabetes mellitus: Review and hypothesis Current Diabetes Reviews 2006, 2:241-59. 10.2174/ 157339906776818541 18220630
39. Mahmoodi MR Abadi AR Kimiagar SM Sex differences in myocardial infarction events between patients with and without conventional risk factors: The Modares Heart Study American Heart Hospital Journal 2007, 5:228-35. 10.1111/j.1541-9215.2007.07301.x 17982303
40. Dotevall A Rosengren A Bartnik M Malmberg K Ohrvik J Simoons M Ryden L European Heart Survey Investigators Sex-related aspects on abnormal glucose regulation in patients with coronary artery disease European Heart Journal 2007, 28:310-5. 10.1093/eurheartj/ehl458 17242006
41. Cubbon RM Rajwani A Abbas A Gale CP Grant PJ Wheatcroft SB Barth JH Kearney MT Hall AS Hyperglycaemia, in relation to sex, and mortality after acute coronary syndrome Eur J Cardiovasc Prev Rehabil 2007, 14(5):666-671. 17925626
42. Levitzky YS Pencina MJ D'Agostino RB Meigs JB Murabito JM Vasan RS Fox CS Impact of impaired fasting glucose on cardiovascular disease: The Framingham Heart Study Journal of the American College of Cardiology 2008, 51:264-70. 10.1016/j.jacc.2007.09.038 18206734
43. Rich-Edwards JW Manson JE Hennekens CH Buring JE The primary prevention of coronary heart disease in women N Engl J Med 1995, 332:1758-1766. 10.1056/NEJM199506293322607 7760894
44. Wingard DL Barrett-Connor E Heart disease and diabetes Diabetes in America Bethesda, MD, National Institutes of Health Harris MI, Cowie CC, Stern MP, Boyko EJ, Reiber GE, Bennett PH 2 1995, 429-448.
45. Wong MCS Short- and long-term discontinuation patterns of commonly prescribed antihypertensive drugs among a Chinese population: Cohort study Journal of Human Hypertension 2008, 22:435-437. 10.1038/ jhh.2008.13 18322547
46. Wong MCS Jiang JY Lam AT Fung H Griffiths S Mercer SW Patterns of antihypertensive prescribing, discontinuation and switching among a Hong Kong Chinese population from over one million prescriptions J Hum Hypertens 2008.
47. Wong MCS Jiang JY Ali MK Fung H Griffiths S Mercer SW Antihypertensive drug class and dyslipidemia: Risk association among Chinese patients with uncomplicated hypertension Journal of Human Hypertension 2008, 22:648-651. 10.1038/jhh.2008.46 18509345